医学
荟萃分析
优势比
子群分析
内科学
乳腺癌
套式病例对照研究
队列研究
肿瘤科
入射(几何)
队列
科克伦图书馆
梅德林
癌症
物理
光学
法学
政治学
作者
Rui Li,Xiuxia Li,Peijing Yan,Zhitong Bing,Liping Cao,Hui Xu,Jing Li,Xingrong Liu,Kehu Yang
出处
期刊:Future Oncology
[Future Medicine]
日期:2021-03-01
卷期号:17 (9): 1105-1124
被引量:7
标识
DOI:10.2217/fon-2020-0822
摘要
Purpose: This study aimed to review the association between antidepressive agent (AD) use and the incidence risk of breast cancer. Methods: CBM, WOS, Embase, PubMed and Cochrane Library were systematically searched in July 2019. The methodological quality of the studies was assessed through the Newcastle-Ottawa Scale. Results: We included 19 studies from six countries or regions with relationships between breast cancer and ADs. Subgroup analysis showed no significant association in nested case-control or case-control studies; however, cohort studies revealed a significant association (odds ratio = 1.11; 95% CI: 1.04-1.17). Conclusions: This meta-analysis indicates that breast cancer was not associated with the use of ADs when considering all types of studies, but an association was observed if we considered cohort studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI